Panagiotis Fotiadis1, Yael D Reijmer1, Susanne J Van Veluw1, Sergi Martinez-Ramirez1, Fikret Isik Karahanoglu1, Elif Gokcal1, Kristin M Schwab1, Joshua N Goldstein1, Jonathan Rosand1, Anand Viswanathan1, Steven M Greenberg1, M Edip Gurol2. 1. From the Hemorrhagic Stroke Research Program, Stroke Research Center, Department of Neurology (P.F., Y.D.R., S.J.V.V., S.M.-R., F.I.K., E.G., K.M.S., A.V., S.M.G., M.E.G.), and Division of Neurocritical Care and Emergency Neurology (J.N.G., J.R.), Massachusetts General Hospital, Harvard Medical School, Boston, MA. 2. From the Hemorrhagic Stroke Research Program, Stroke Research Center, Department of Neurology (P.F., Y.D.R., S.J.V.V., S.M.-R., F.I.K., E.G., K.M.S., A.V., S.M.G., M.E.G.), and Division of Neurocritical Care and Emergency Neurology (J.N.G., J.R.), Massachusetts General Hospital, Harvard Medical School, Boston, MA. edip@mail.harvard.edu.
Abstract
OBJECTIVE: We postulated that cerebral amyloid angiopathy (CAA) is associated with white matter atrophy (WMA) and that WMA can be related to cognitive changes in CAA. METHODS: White matter volume expressed as percent of intracranial volume (pWMV) of prospectively enrolled patients without dementia diagnosed with probable CAA was compared to age-matched healthy controls (HC) and patients with Alzheimer disease (AD). Cognitive scores were also sought to understand the potential effects of WMA on cognitive function. RESULTS: Patients with CAA (n = 72) had significantly lower pWMV (27.97% ± 2.63) when compared to age-matched HC (n = 72; mean difference [MD], 2.38%; p < 0.0001) and patients with AD (n = 72; MD, 1.57%; p < 0.0001). Differences were most pronounced in the posterior occipital regions in both comparisons. When comparisons were restricted to groups of patients with CAA but no intracerebral hemorrhage (n = 32) or hypertension (n = 32), and age-matched HC and AD, the significant differences were unaltered. Within the CAA cohort, higher age, lobar microbleed counts, and presence of hypertension were associated with lower pWMV (p = 0.0007, p = 0.031, and p = 0.003, respectively). All associations remained independent in multivariable analyses. Within the CAA cohort, higher pWMV independently correlated with better scores of executive function. CONCLUSIONS: Patients with CAA show WMA when compared to age-matched HC and patients with AD. WMA independently correlates with the number of lobar microbleeds, a marker of CAA severity. Consistent spatial patterns of WMA especially in posterior regions might be related to CAA. The association between WMA and measures of executive function suggests that WMA might represent an important mediator of CAA-related neurologic dysfunction.
OBJECTIVE: We postulated that cerebral amyloid angiopathy (CAA) is associated with white matter atrophy (WMA) and that WMA can be related to cognitive changes in CAA. METHODS: White matter volume expressed as percent of intracranial volume (pWMV) of prospectively enrolled patients without dementia diagnosed with probable CAA was compared to age-matched healthy controls (HC) and patients with Alzheimer disease (AD). Cognitive scores were also sought to understand the potential effects of WMA on cognitive function. RESULTS: Patients with CAA (n = 72) had significantly lower pWMV (27.97% ± 2.63) when compared to age-matched HC (n = 72; mean difference [MD], 2.38%; p < 0.0001) and patients with AD (n = 72; MD, 1.57%; p < 0.0001). Differences were most pronounced in the posterior occipital regions in both comparisons. When comparisons were restricted to groups of patients with CAA but no intracerebral hemorrhage (n = 32) or hypertension (n = 32), and age-matched HC and AD, the significant differences were unaltered. Within the CAA cohort, higher age, lobar microbleed counts, and presence of hypertension were associated with lower pWMV (p = 0.0007, p = 0.031, and p = 0.003, respectively). All associations remained independent in multivariable analyses. Within the CAA cohort, higher pWMV independently correlated with better scores of executive function. CONCLUSIONS: Patients with CAA show WMA when compared to age-matched HC and patients with AD. WMA independently correlates with the number of lobar microbleeds, a marker of CAA severity. Consistent spatial patterns of WMA especially in posterior regions might be related to CAA. The association between WMA and measures of executive function suggests that WMA might represent an important mediator of CAA-related neurologic dysfunction.
Authors: Jonathan Rosand; Alona Muzikansky; Ashok Kumar; Jonathan J Wisco; Eric E Smith; Rebecca A Betensky; Steven M Greenberg Journal: Ann Neurol Date: 2005-09 Impact factor: 10.422
Authors: Susanne J van Veluw; Andreas Charidimou; Andre J van der Kouwe; Arne Lauer; Yael D Reijmer; Isabel Costantino; M Edip Gurol; Geert Jan Biessels; Matthew P Frosch; Anand Viswanathan; Steven M Greenberg Journal: Brain Date: 2016-09-19 Impact factor: 13.501
Authors: Zoe Arvanitakis; Sue E Leurgans; Zhenxin Wang; Robert S Wilson; David A Bennett; Julie A Schneider Journal: Ann Neurol Date: 2010-11-08 Impact factor: 10.422
Authors: M Edip Gurol; Gregory Dierksen; Rebecca Betensky; Christopher Gidicsin; Amy Halpin; Alex Becker; Jeremy Carmasin; Alison Ayres; Kristin Schwab; Anand Viswanathan; David Salat; Jonathan Rosand; Keith A Johnson; Steven M Greenberg Journal: Neurology Date: 2012-07-11 Impact factor: 9.910
Authors: Panagiotis Fotiadis; Sanneke van Rooden; Jeroen van der Grond; Aaron Schultz; Sergi Martinez-Ramirez; Eitan Auriel; Yael Reijmer; Anna M van Opstal; Alison Ayres; Kristin M Schwab; Trey Hedden; Jonathan Rosand; Anand Viswanathan; Marieke Wermer; Gisela Terwindt; Reisa A Sperling; Jonathan R Polimeni; Keith A Johnson; Mark A van Buchem; Steven M Greenberg; M Edip Gurol Journal: Lancet Neurol Date: 2016-05-11 Impact factor: 44.182
Authors: M Edip Gurol; J Alex Becker; Panagiotis Fotiadis; Grace Riley; Kristin Schwab; Keith A Johnson; Steven M Greenberg Journal: Neurology Date: 2016-09-07 Impact factor: 9.910
Authors: Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans Journal: Lancet Neurol Date: 2013-08 Impact factor: 44.182
Authors: Charles Beaman; Krystyna Kozii; Saima Hilal; Minghua Liu; Anthony J Spagnolo-Allende; Guillermo Polanco-Serra; Christopher Chen; Ching-Yu Cheng; Daniela Zambrano; Burak Arikan; Victor J Del Brutto; Clinton Wright; Xena E Flowers; Sandra P Leskinen; Tatjana Rundek; Amanda Mitchell; Jean Paul Vonsattel; Etty Cortes; Andrew F Teich; Ralph L Sacco; Mitchell S V Elkind; David Roh; Jose Gutierrez Journal: Neurology Date: 2022-02-28 Impact factor: 11.800
Authors: Elif Gokcal; Mitchell J Horn; J Alex Becker; Alvin S Das; Kristin Schwab; Alessandro Biffi; Natalia Rost; Jonathan Rosand; Anand Viswanathan; Jonathan R Polimeni; Keith A Johnson; Steven M Greenberg; M Edip Gurol Journal: J Cereb Blood Flow Metab Date: 2022-01-28 Impact factor: 6.960
Authors: Whitney M Freeze; Maria Clara Zanon Zotin; Ashley A Scherlek; Valentina Perosa; Corinne A Auger; Andrew D Warren; Louise van der Weerd; Dorothee Schoemaker; Mitchell J Horn; M Edip Gurol; Elif Gokcal; Brian J Bacskai; Anand Viswanathan; Steven M Greenberg; Yael D Reijmer; Susanne J van Veluw Journal: Brain Commun Date: 2022-04-26
Authors: Panagiotis Fotiadis; Marco Pasi; Andreas Charidimou; Andrew D Warren; Kristin M Schwab; Jonathan Rosand; Jeroen van der Grond; Mark A van Buchem; Anand Viswanathan; M Edip Gurol; Steven M Greenberg Journal: J Stroke Date: 2021-05-31 Impact factor: 6.967
Authors: Ibrahim Shaikh; Christian Beaulieu; Myrlene Gee; Cheryl R McCreary; Andrew E Beaudin; Diana Valdés-Cabrera; Eric E Smith; Richard Camicioli Journal: Neuroimage Clin Date: 2022-04-04 Impact factor: 4.891